However, further investigations are recommended to evaluate the interplay between FLT3-ITD and acid ceramidase in acute myeloid leukemia chemo-resistance and subsequently, more clinical, in-vitro, and in-vivo studies are needed to better understand these mechanisms and prepare therapeutic strategies for them. This evidence concerns the gene FLT3 and acute myeloid leukemia.